高级检索
当前位置: 首页 > 详情页

Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression.

文献详情

资源类型:
Pubmed体系:
机构: [1]Liver Transplantation Division, Department of Liver Surgery, West ChinaHospital, Sichuan University, Chengdu, People’s Republic of China [2]Department of Bioengineering and Therapeutic Sciences and Liver Center,University of California, San Francisco, CA, USA [3]Laboratory of Liver Surgery,West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republicof China [4]Department of General Surgery, The Second Affiliated Hospital ofXi’an Jiaotong University, Xi’an Jiaotong University, Xi’an, People’s Republic ofChina [5]Institute of Pathology, University of Regensburg, Regensburg, Germany
出处:

摘要:
Dysregulation of transforming growth factor-beta (TGFβ) signaling has been implicated in liver carcinogenesis with both tumor promoting and inhibiting activities. Activation of the c-MYC protooncogene is another critical genetic event in hepatocellular carcinoma (HCC). However, the precise functional crosstalk between c-MYC and TGFβ signaling pathways remains unclear. In the present investigation, we investigated the expression of TGFβ signaling in c-MYC amplified human HCC samples as well as the mechanisms whereby TGFβ modulates c-Myc driven hepatocarcinogenesis during initiation and progression. We found that several TGFβ target genes are overexpressed in human HCCs with c-MYC amplification. In vivo, activation of TGFβ1 impaired c-Myc murine HCC initiation, whereas inhibition of TGFβ pathway accelerated this process. In contrast, overexpression of TGFβ1 enhanced c-Myc HCC progression by promoting tumor cell metastasis. Mechanistically, activation of TGFβ promoted tumor microenvironment reprogramming rather than inducing epithelial-to-mesenchymal transition during HCC progression. Moreover, we identified PMEPA1 as a potential TGFβ1 target. Altogether, our data underline the divergent roles of TGFβ signaling during c-MYC induced HCC initiation and progression.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
最新[2023]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
第一作者:
第一作者机构: [1]Liver Transplantation Division, Department of Liver Surgery, West ChinaHospital, Sichuan University, Chengdu, People’s Republic of China [2]Department of Bioengineering and Therapeutic Sciences and Liver Center,University of California, San Francisco, CA, USA [3]Laboratory of Liver Surgery,West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republicof China
通讯作者:
通讯机构: [1]Liver Transplantation Division, Department of Liver Surgery, West ChinaHospital, Sichuan University, Chengdu, People’s Republic of China [3]Laboratory of Liver Surgery,West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republicof China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52808 今日访问量:0 总访问量:4561 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号